ArticlePharmaceutics2023

Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment-TUMMY Study.

Merve Sivridaş et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.